Subtype
Lung Carcinoma
CI-CAN-00001086Explore in graph →
2,130 active trials51 approved drugs598 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001086Explore in graph →
Clinical trials
7,792 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04748523 | Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia | completed | N/A | 86 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT05815472 | Advanced Patient Monitoring and A.I. Supported Outcomes Assessment in Lung Cancer Using Internet of Things Technologies (A.I. - APALITT)(APALITT) | unknown | N/A | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER |
| 1 |
| Apr 18, 2023 |
| clinicaltrials |
| NCT03908671 | Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer | unknown | N/A | 24 | Stemirna TherapeuticsINDUSTRY | 1 | Apr 13, 2023 | clinicaltrials |
| NCT02758054 | Patient Navigation for Lung Cancer Screening in an Urban Safety-Net System | completed | N/A | 447 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 6, 2023 | clinicaltrials |
| NCT02035683 | PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy(PETRA) | unknown | N/A | 220 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT02456246 | Piloting the Feasibility of FLT-PET/CT Non-Small Cell Lung Cancer Managed With SBRT(SBRT FLT-PET) | completed | N/A | 45 | University Health Network, TorontoOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT05620199 | Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy(UPLAN-I) | unknown | N/A | 20 | The Netherlands Cancer InstituteOTHER | 0 | Mar 20, 2023 | clinicaltrials |
| NCT01840150 | Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung Cancer | completed | N/A | 41 | Fox Chase Cancer CenterOTHER | 1 | Mar 13, 2023 | clinicaltrials |
| NCT02136355 | A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer | completed | N/A | 40 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT04159025 | EBUS-Miniforceps Biopsy Specimen Acquisition for PD-L1 Testing in Nonsmall Cell Lung Cancer | completed | N/A | 20 | Washington University School of MedicineOTHER | 1 | Mar 1, 2023 | clinicaltrials |
| NCT03707925 | Bronchoscopic Laser Ablation of Peripheral Lung Tumors | terminated | N/A | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 16, 2023 | clinicaltrials |
| NCT05698264 | A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC | not yet recruiting | N/A | 50 | Nir PeledOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04941365 | Quantifying Systemic Immunosuppression to Personalize Cancer Therapy(SERPENTINE) | withdrawn | N/A | 0 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 0 | Dec 22, 2022 | clinicaltrials |
| NCT04436406 | PD-L1 Expression in Cancer (PECan Study).(PECan) | unknown | N/A | 30 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Dec 15, 2022 | clinicaltrials |
| NCT04758481 | Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer | unknown | N/A | 20 | University Hospital OstravaOTHER | 1 | Dec 7, 2022 | clinicaltrials |
| NCT04720339 | Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy. | recruiting | N/A | 250 | University Hospital, Strasbourg, FranceOTHER | 1 | Nov 23, 2022 | clinicaltrials |
| NCT05611450 | Mobile Health Application of Disease Self-Management in Non-Small Cell Lung Cancer Patients During Targeted Therapy | unknown | N/A | 108 | Chang Gung Memorial HospitalOTHER | 0 | Nov 10, 2022 | clinicaltrials |
| NCT02728596 | S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)(TrACER) | completed | N/A | 3,665 | SWOG Cancer Research NetworkNETWORK | 2 | Oct 20, 2022 | clinicaltrials |
| NCT05583409 | SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC | unknown | N/A | 72 | Li ZhangOTHER | 1 | Oct 17, 2022 | clinicaltrials |
| NCT05577052 | SBRT Versus Conventional Fractionated Radiotherapy for Vertebral Metastases | unknown | N/A | 100 | Wuhan UniversityOTHER | 0 | Oct 13, 2022 | clinicaltrials |
| NCT01860898 | A Phase I Study of iPS Cell Generation From Patients With COPD | completed | N/A | 31 | Mayo ClinicOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT04635761 | Awareness, Information, and Resources for Lung Cancer Screening Program for Community-Partnered Lung Cancer Screening | completed | N/A | 292 | Roswell Park Cancer InstituteOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT04455438 | SBRT Dose Escalation for Reirradiation of Inoperable Lung Lesions(STRILL) | unknown | N/A | 15 | Istituto Clinico HumanitasOTHER | 1 | Sep 15, 2022 | clinicaltrials |
| NCT05532527 | Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study(NSCLC) | unknown | N/A | 35 | Henan Provincial People's HospitalOTHER | 0 | Sep 8, 2022 | clinicaltrials |
| NCT00637624 | N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy(NAC-PNP) | terminated | N/A | 69 | Rijnstate HospitalOTHER | 1 | Aug 25, 2022 | clinicaltrials |
| NCT00198341 | Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up | completed | N/A | 1,775 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Aug 10, 2022 | clinicaltrials |
| NCT03971175 | Influence of Biopsy Technique on Moleculargenetic Tumor Characterisation in NSCLC(PROFILER) | unknown | N/A | 540 | University Hospital TuebingenOTHER | 1 | Jul 26, 2022 | clinicaltrials |
| NCT01896778 | Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer | completed | N/A | 9 | Roswell Park Cancer InstituteOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT04922697 | Educational Intervention for the Promotion of Knowledge and Preventive Health Behaviors Related to Personal Air Pollution Exposure, The Air Study | completed | N/A | 25 | Fred Hutchinson Cancer CenterOTHER | 1 | Jul 21, 2022 | clinicaltrials |
| NCT05027100 | Tislelizumab Combined With Anlotinib and 2-cycles Irinotecan as Second Line Treatment of SCLC | unknown | N/A | 33 | Haibo ZhangOTHER | 1 | Jul 1, 2022 | clinicaltrials |
| NCT05426317 | Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression(Onco-PDL1s/B2M) | unknown | N/A | 100 | University Hospital, Clermont-FerrandOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT02319408 | Immune Boost In Non-Small Cell Lung Cancer(RadImmune) | completed | N/A | 36 | University Hospital HeidelbergOTHER | 1 | May 23, 2022 | clinicaltrials |
| NCT03569072 | High Intensity Functional Image Guided Vmat Lung Evasion(HI-FIVE) | completed | N/A | 19 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | May 19, 2022 | clinicaltrials |
| NCT03700437 | Fasting-mimicking Diet With Chemo-immunotherapy in Non-small Cell Lung Cancer (NSCLC) | completed | N/A | 12 | Indiana UniversityOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT02995889 | FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer | completed | N/A | 64 | Rigshospitalet, DenmarkOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT02995902 | FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer(SIBES II) | completed | N/A | 13 | Rigshospitalet, DenmarkOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT03606239 | NSCLC Isotoxic Hypofractionated Chemoradiotherapy(IHRC) | unknown | N/A | 30 | The Second Hospital of Hebei Medical UniversityOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT03606291 | NSCLC Isotoxic Hypofractionated Radiotherapy(IHR) | unknown | N/A | 30 | The Second Hospital of Hebei Medical UniversityOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT03563482 | Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy. | unknown | N/A | 500 | Istituto Clinico HumanitasOTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT03997799 | Comparison of Two Techniques of Uniportal VATS Lobectomies for Clinical Stage I Non-Small Cell Lung Cancer | unknown | N/A | 20 | Pulmonary Hospital ZakopaneOTHER | 1 | Apr 26, 2022 | clinicaltrials |
| NCT02354274 | Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant Navelbine® | recruiting | N/A | 330 | Olfred HansenOTHER | 1 | Apr 25, 2022 | clinicaltrials |
| NCT05320458 | Pulmonary Rehabılıtatıon Wıth Non-Small Lung Cancer | unknown | N/A | 11 | Hasan Kalyoncu UniversityOTHER | 1 | Apr 11, 2022 | clinicaltrials |
| NCT00875901 | Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)(LU03) | completed | N/A | 23 | University of FloridaOTHER | 1 | Mar 24, 2022 | clinicaltrials |
| NCT05291780 | Stereotactic Ablative Radiotherapy in Locally Advanced Non Small Cell Lung Cancer(START-NEW-ERA) | completed | N/A | 80 | Radiotherapy Oncology Centre "Santa Maria" HospitalOTHER | 1 | Mar 23, 2022 | clinicaltrials |
| NCT04828850 | Preoperative Lymph Node Staging With EBUS-TBNA in Clinical N0 Non Small-cell Lung Cancer | unknown | N/A | 50 | European Institute of OncologyOTHER | 1 | Mar 22, 2022 | clinicaltrials |
| NCT05279521 | The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer. | unknown | N/A | 104 | National Taiwan University HospitalOTHER | 0 | Mar 15, 2022 | clinicaltrials |
| NCT00246116 | Functional Imaging of Treatment Effects: A Companion Protocol to a Study of Extracranial Stereotactic Radioablation in Early Stage Non-Small Cell Lung Cancer(SBF Companion) | completed | N/A | 15 | Indiana UniversityOTHER | 0 | Feb 11, 2022 | clinicaltrials |
| NCT05218759 | Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC | unknown | N/A | 30 | Shanghai Chest HospitalOTHER | 0 | Feb 1, 2022 | clinicaltrials |
| NCT03988192 | Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic Response(Immuno-VOC) | terminated | N/A | 60 | Hopital FochOTHER | 1 | Jan 27, 2022 | clinicaltrials |
| NCT05210946 | A Single-Arm Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients | unknown | N/A | 20 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Jan 27, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Apr 27, 2023source: clinicaltrials